<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>4568946 Figure_1-B</id>
    <infon key="sourcedata_document">1548</infon>
    <infon key="doi">10.15252/emmm.201404914</infon>
    <infon key="pmc_id">4568946</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>Examples of CT scanimages of several metastases (M032R1, M032R2, and M032R5).</text>
      <annotation id="1">
        <infon key="type">tissue:metastases</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">179</infon>
        <location offset="37" length="10"/>
        <text>metastases</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4568946 Figure_1-C</id>
    <infon key="sourcedata_document">1548</infon>
    <infon key="doi">10.15252/emmm.201404914</infon>
    <infon key="pmc_id">4568946</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>Volumetric measurements based on the PET and CT scans could be generated from M032, M032R1, and M032R5. Graph illustrates that the metastases R1 and R5 initially expanded before the start of the treatment, but regressed upon vemurafenib treatment. M032R5 showed progressive disease after 4 months, whereas M032R1 still displayed stable disease. M032 was excised and no recurrence was observed.</text>
      <annotation id="1">
        <infon key="type">CHEBI:63637</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">143</infon>
        <location offset="225" length="11"/>
        <text>vemurafenib</text>
      </annotation>
      <annotation id="2">
        <infon key="type">tissue:metastases</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">180</infon>
        <location offset="131" length="10"/>
        <text>metastases</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4568946 Figure_2-A</id>
    <infon key="sourcedata_document">1548</infon>
    <infon key="doi">10.15252/emmm.201404914</infon>
    <infon key="pmc_id">4568946</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>Hematoxylin-eosin (H&amp;E) and p-ERK stainings on FFPE material of all metastases showed that all vemurafenib-resistant tumors had reactivation of the MAPK pathway. Scale bar represents 100 &#956;m</text>
      <annotation id="1">
        <infon key="type">Uniprot:P27361|Uniprot:P28482</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">14</infon>
        <location offset="30" length="3"/>
        <text>ERK</text>
      </annotation>
      <annotation id="2">
        <infon key="type">CHEBI:63637</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">15</infon>
        <location offset="95" length="11"/>
        <text>vemurafenib</text>
      </annotation>
      <annotation id="3">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">17</infon>
        <location offset="117" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="4">
        <infon key="type">tissue:metastases</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">181</infon>
        <location offset="68" length="10"/>
        <text>metastases</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4568946 Figure_2-C</id>
    <infon key="sourcedata_document">1548</infon>
    <infon key="doi">10.15252/emmm.201404914</infon>
    <infon key="pmc_id">4568946</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>qPCR was performed on gDNA retrieved from each of the metastases, using primers for BRAF and CRAF and normalized on LINE levels. Bars represent the mean of three replicates, error bars indicate standard deviation. The results confirmed that BRAF was amplified in M032R1, M032R2, and M032R5.</text>
      <annotation id="1">
        <infon key="type">CHEBI:4705</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">18</infon>
        <location offset="22" length="4"/>
        <text>gDNA</text>
      </annotation>
      <annotation id="2">
        <infon key="type">NCBI gene:5894</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">19</infon>
        <location offset="93" length="4"/>
        <text>CRAF</text>
      </annotation>
      <annotation id="3">
        <infon key="type">NCBI gene:673</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">21</infon>
        <location offset="84" length="4"/>
        <text>BRAF</text>
      </annotation>
      <annotation id="4">
        <infon key="type">NCBI gene:673</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">22</infon>
        <location offset="241" length="4"/>
        <text>BRAF</text>
      </annotation>
      <annotation id="5">
        <infon key="type">tissue:metastases</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">182</infon>
        <location offset="54" length="10"/>
        <text>metastases</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4568946 Figure_2-D</id>
    <infon key="sourcedata_document">1548</infon>
    <infon key="doi">10.15252/emmm.201404914</infon>
    <infon key="pmc_id">4568946</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>Staining for BRAFV600E with a mutant epitope-specific antibody confirmed the upregulation of BRAFV600E in R1, R2, and R5. Scale bar represents 100 &#956;m.</text>
      <annotation id="1">
        <infon key="type">Uniprot:P15056</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">25</infon>
        <location offset="93" length="4"/>
        <text>BRAF</text>
      </annotation>
      <annotation id="2">
        <infon key="type">Uniprot:P15056</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">26</infon>
        <location offset="13" length="4"/>
        <text>BRAF</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4568946 Figure_3-A</id>
    <infon key="sourcedata_document">1548</infon>
    <infon key="doi">10.15252/emmm.201404914</infon>
    <infon key="pmc_id">4568946</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>Immunoblotting for MAPK pathway components confirmed reactivation of p-ERK and p-MEK in all resistant metastases.</text>
      <annotation id="1">
        <infon key="type">Uniprot:Q02750|Uniprot:P36507</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">28</infon>
        <location offset="81" length="3"/>
        <text>MEK</text>
      </annotation>
      <annotation id="2">
        <infon key="type">Uniprot:P27361|Uniprot:P28482</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">29</infon>
        <location offset="71" length="3"/>
        <text>ERK</text>
      </annotation>
      <annotation id="3">
        <infon key="type">tissue:metastases</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">183</infon>
        <location offset="102" length="10"/>
        <text>metastases</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4568946 Figure_3-B</id>
    <infon key="sourcedata_document">1548</infon>
    <infon key="doi">10.15252/emmm.201404914</infon>
    <infon key="pmc_id">4568946</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>Immunoblotting for M032 patient's samples using an antibody directed against either the mutant BRAFV600E epitope or an N-terminal region of BRAF revealed the expression of a shorter variant of BRAFV600E in M032R3, of approximately 80 kDa. This 80-kDa band could not be detected with the N-terminus-recognizing antibody.</text>
      <annotation id="1">
        <infon key="type">Uniprot:P15056</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">36</infon>
        <location offset="193" length="4"/>
        <text>BRAF</text>
      </annotation>
      <annotation id="2">
        <infon key="type">NCBI taxon:9606</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">38</infon>
        <location offset="24" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="3">
        <infon key="type">Uniprot:P15056</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">39</infon>
        <location offset="95" length="4"/>
        <text>BRAF</text>
      </annotation>
      <annotation id="4">
        <infon key="type">Uniprot:P15056</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">40</infon>
        <location offset="140" length="4"/>
        <text>BRAF</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4568946 Figure_4-C</id>
    <infon key="sourcedata_document">1548</infon>
    <infon key="doi">10.15252/emmm.201404914</infon>
    <infon key="pmc_id">4568946</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>Validation of T55delinsRT was done by PCR using insertion-specific primers. As a control, primers amplifying exon 2 of MEK1WT were used.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:5604</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">47</infon>
        <location offset="119" length="4"/>
        <text>MEK1</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4568946 Figure_4-D</id>
    <infon key="sourcedata_document">1548</infon>
    <infon key="doi">10.15252/emmm.201404914</infon>
    <infon key="pmc_id">4568946</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>Transfection of pQXCIP-GFP, MEK1-WT, or MEK1-T55delinsRT into HEK293T cells showed that this mutation induces p-ERK and p-RSK.</text>
      <annotation id="1">
        <infon key="type">Uniprot:P27361|Uniprot:P28482</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">51</infon>
        <location offset="112" length="3"/>
        <text>ERK</text>
      </annotation>
      <annotation id="2">
        <infon key="type">Uniprot:Q15418|Uniprot:P23443</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">52</infon>
        <location offset="122" length="3"/>
        <text>RSK</text>
      </annotation>
      <annotation id="3">
        <infon key="type">NCBI gene:5604</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">53</infon>
        <location offset="28" length="4"/>
        <text>MEK1</text>
      </annotation>
      <annotation id="4">
        <infon key="type">NCBI gene:5604</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">54</infon>
        <location offset="40" length="4"/>
        <text>MEK1</text>
      </annotation>
      <annotation id="5">
        <infon key="type">CVCL_0063</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">55</infon>
        <location offset="62" length="7"/>
        <text>HEK293T</text>
      </annotation>
      <annotation id="6">
        <infon key="type">gene:GFP</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">188</infon>
        <location offset="23" length="3"/>
        <text>GFP</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4568946 Figure_4-E</id>
    <infon key="sourcedata_document">1548</infon>
    <infon key="doi">10.15252/emmm.201404914</infon>
    <infon key="pmc_id">4568946</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>Validation of expression of pQXCIP-GFP, MEK1WT, or MEK1T55delinsRT in A375 melanoma cells by immunoblotting.</text>
      <annotation id="1">
        <infon key="type">CVCL_0132</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">59</infon>
        <location offset="70" length="4"/>
        <text>A375</text>
      </annotation>
      <annotation id="2">
        <infon key="type">NCBI gene:5604</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">61</infon>
        <location offset="40" length="4"/>
        <text>MEK1</text>
      </annotation>
      <annotation id="3">
        <infon key="type">NCBI gene:5604</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">62</infon>
        <location offset="51" length="4"/>
        <text>MEK1</text>
      </annotation>
      <annotation id="4">
        <infon key="type">gene:GFP</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">189</infon>
        <location offset="35" length="3"/>
        <text>GFP</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4568946 Figure_4-F</id>
    <infon key="sourcedata_document">1548</infon>
    <infon key="doi">10.15252/emmm.201404914</infon>
    <infon key="pmc_id">4568946</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>Dose-response curves for A375 melanoma cells expressing GFP, MEK1WT, or MEK1T55delinsRT with indicated doses of BRAF inhibitor vemurafenib, ERK inhibitor SCH772984, or MEK inhibitor trametinib. Error bars indicate standard deviation.</text>
      <annotation id="1">
        <infon key="type">PubChem:24866313</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">70</infon>
        <location offset="154" length="9"/>
        <text>SCH772984</text>
      </annotation>
      <annotation id="2">
        <infon key="type">CHEBI:75998</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">71</infon>
        <location offset="182" length="10"/>
        <text>trametinib</text>
      </annotation>
      <annotation id="3">
        <infon key="type">CVCL_0132</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">73</infon>
        <location offset="25" length="4"/>
        <text>A375</text>
      </annotation>
      <annotation id="4">
        <infon key="type">NCBI gene:5604</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">75</infon>
        <location offset="61" length="4"/>
        <text>MEK1</text>
      </annotation>
      <annotation id="5">
        <infon key="type">NCBI gene:5604</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">76</infon>
        <location offset="72" length="4"/>
        <text>MEK1</text>
      </annotation>
      <annotation id="6">
        <infon key="type">NCBI gene:673</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">77</infon>
        <location offset="112" length="4"/>
        <text>BRAF</text>
      </annotation>
      <annotation id="7">
        <infon key="type">CHEBI:63637</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">78</infon>
        <location offset="127" length="11"/>
        <text>vemurafenib</text>
      </annotation>
      <annotation id="8">
        <infon key="type">NCBI gene:5594|NCBI gene:5595</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">82</infon>
        <location offset="140" length="3"/>
        <text>ERK</text>
      </annotation>
      <annotation id="9">
        <infon key="type">gene:GFP</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">190</infon>
        <location offset="56" length="3"/>
        <text>GFP</text>
      </annotation>
      <annotation id="10">
        <infon key="type">NCBI gene:5604|NCBI gene:5605</infon>
        <infon key="sourcedata_figure_annot_id">11</infon>
        <infon key="sourcedata_article_annot_id">191</infon>
        <location offset="168" length="3"/>
        <text>MEK</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4568946 Figure_4-G</id>
    <infon key="sourcedata_document">1548</infon>
    <infon key="doi">10.15252/emmm.201404914</infon>
    <infon key="pmc_id">4568946</infon>
    <infon key="figure">Figure 4-G</infon>
    <infon key="sourcedata_figure_dir">Figure_4-G</infon>
    <passage>
      <offset>0</offset>
      <text>Colony formation assays with A375 melanoma cells, infected with GFP, MEK1WT, or MEK1T55delinsRT-encoding lentivirus, and treated with indicated doses and inhibitors.</text>
      <annotation id="1">
        <infon key="type">gene:GFP</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">85</infon>
        <location offset="64" length="3"/>
        <text>GFP</text>
      </annotation>
      <annotation id="2">
        <infon key="type">CVCL_0132</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">86</infon>
        <location offset="29" length="4"/>
        <text>A375</text>
      </annotation>
      <annotation id="3">
        <infon key="type">NCBI gene:5604</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">87</infon>
        <location offset="69" length="4"/>
        <text>MEK1</text>
      </annotation>
      <annotation id="4">
        <infon key="type">NCBI gene:5604</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">88</infon>
        <location offset="80" length="4"/>
        <text>MEK1</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4568946 Figure_4-H</id>
    <infon key="sourcedata_document">1548</infon>
    <infon key="doi">10.15252/emmm.201404914</infon>
    <infon key="pmc_id">4568946</infon>
    <infon key="figure">Figure 4-H</infon>
    <infon key="sourcedata_figure_dir">Figure_4-H</infon>
    <passage>
      <offset>0</offset>
      <text>Treatment of A375MEK1T55delinsRT melanoma cells with DMSO (&#8722;), 250 nM dabrafenib (D), 10 nM trametinib (T), or a combination (D+T).</text>
      <annotation id="1">
        <infon key="type">CHEBI:75045</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">97</infon>
        <location offset="72" length="10"/>
        <text>dabrafenib</text>
      </annotation>
      <annotation id="2">
        <infon key="type">CVCL_0132</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">98</infon>
        <location offset="13" length="4"/>
        <text>A375</text>
      </annotation>
      <annotation id="3">
        <infon key="type">NCBI gene:5604</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">99</infon>
        <location offset="17" length="4"/>
        <text>MEK1</text>
      </annotation>
      <annotation id="4">
        <infon key="type">CHEBI:28262</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">100</infon>
        <location offset="53" length="4"/>
        <text>DMSO</text>
      </annotation>
      <annotation id="5">
        <infon key="type">CHEBI:75998</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">101</infon>
        <location offset="94" length="10"/>
        <text>trametinib</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4568946 Figure_5-A</id>
    <infon key="sourcedata_document">1548</infon>
    <infon key="doi">10.15252/emmm.201404914</infon>
    <infon key="pmc_id">4568946</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>A375 melanoma cells expressing GFP, MEK1WT, or MEK1T55delinsRT were injected into immune-deficient mice (n = 8 per group), and after the tumor size of &#732;100 mm3 was reached, mice were treated with 30 mg/kg dabrafenib or vehicle. Graphs represent fold change in tumor volume normalized on the tumor volume on the day of the start of the treatment. Error bars indicate standard error of the mean.</text>
      <annotation id="1">
        <infon key="type">gene:GFP</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">103</infon>
        <location offset="31" length="3"/>
        <text>GFP</text>
      </annotation>
      <annotation id="2">
        <infon key="type">CVCL_0132</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">104</infon>
        <location offset="0" length="4"/>
        <text>A375</text>
      </annotation>
      <annotation id="3">
        <infon key="type">NCBI gene:5604</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">105</infon>
        <location offset="36" length="4"/>
        <text>MEK1</text>
      </annotation>
      <annotation id="4">
        <infon key="type">NCBI gene:5604</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">106</infon>
        <location offset="47" length="4"/>
        <text>MEK1</text>
      </annotation>
      <annotation id="5">
        <infon key="type">NCBI taxon:10090</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">107</infon>
        <location offset="99" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="6">
        <infon key="type">NCBI taxon:10090</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">108</infon>
        <location offset="174" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="7">
        <infon key="type">CHEBI:75045</infon>
        <infon key="sourcedata_figure_annot_id">7</infon>
        <infon key="sourcedata_article_annot_id">109</infon>
        <location offset="206" length="10"/>
        <text>dabrafenib</text>
      </annotation>
      <annotation id="8">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">8</infon>
        <infon key="sourcedata_article_annot_id">110</infon>
        <location offset="137" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="9">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">9</infon>
        <infon key="sourcedata_article_annot_id">111</infon>
        <location offset="261" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="10">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">10</infon>
        <infon key="sourcedata_article_annot_id">112</infon>
        <location offset="292" length="5"/>
        <text>tumor</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4568946 Figure_5-B</id>
    <infon key="sourcedata_document">1548</infon>
    <infon key="doi">10.15252/emmm.201404914</infon>
    <infon key="pmc_id">4568946</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>Average tumor weight of all groups at the end of the experiment described in (A). Error bars indicate standard deviation. Unpaired t-test was used to calculate statistical significance. P-values are indicated in the graph.</text>
      <annotation id="1">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">115</infon>
        <location offset="8" length="5"/>
        <text>tumor</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4568946 Figure_5-C</id>
    <infon key="sourcedata_document">1548</infon>
    <infon key="doi">10.15252/emmm.201404914</infon>
    <infon key="pmc_id">4568946</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>Immunoblotting for MAPK pathway components performed on tumors of all groups.</text>
      <annotation id="1">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">124</infon>
        <location offset="56" length="6"/>
        <text>tumors</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4568946 Figure_5-D</id>
    <infon key="sourcedata_document">1548</infon>
    <infon key="doi">10.15252/emmm.201404914</infon>
    <infon key="pmc_id">4568946</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>Immunohistochemistry for Sirius Red (staining for collagen) and H&amp;E on tumors from all groups, to identify grade of demarcation and local invasion. Scale bar represents 500 (upper row) and 100 (lower row) &#956;m.</text>
      <annotation id="1">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">140</infon>
        <location offset="71" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="2">
        <infon key="type">GO:0098645</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">141</infon>
        <location offset="50" length="8"/>
        <text>collagen</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4568946 Figure_6-A</id>
    <infon key="sourcedata_document">1548</infon>
    <infon key="doi">10.15252/emmm.201404914</infon>
    <infon key="pmc_id">4568946</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>gDNA was isolated from another fragment of the tumor resection, and the PCR with the insertion-specific primers was repeated. Primers amplifying exon 2 of MEK1WT were used as an input control. Source data are available online for this figure.</text>
      <annotation id="1">
        <infon key="type">Uberon:UBERON:0000479</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">146</infon>
        <location offset="47" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="2">
        <infon key="type">NCBI gene:5604</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">148</infon>
        <location offset="155" length="4"/>
        <text>MEK1</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4568946 Figure_7-A</id>
    <infon key="sourcedata_document">1548</infon>
    <infon key="doi">10.15252/emmm.201404914</infon>
    <infon key="pmc_id">4568946</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>Staining for hematoxylin-eosin (H&amp;E) and p-ERK on the PDX samples M032.X1, M032R1.X1, M032R2.X1, M032R4.X1, and M032R5.X1. Stainings showed that p-ERK is higher in the PDX derived from the resistant metastases. Scale bar represents 100 &#956;m.</text>
      <annotation id="1">
        <infon key="type">Uniprot:P27361|Uniprot:P28482</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">154</infon>
        <location offset="43" length="3"/>
        <text>ERK</text>
      </annotation>
      <annotation id="2">
        <infon key="type">Uniprot:P27361|Uniprot:P28482</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">155</infon>
        <location offset="147" length="3"/>
        <text>ERK</text>
      </annotation>
      <annotation id="3">
        <infon key="type">tissue:metastases</infon>
        <infon key="sourcedata_figure_annot_id">5</infon>
        <infon key="sourcedata_article_annot_id">192</infon>
        <location offset="199" length="10"/>
        <text>metastases</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4568946 Figure_7-B</id>
    <infon key="sourcedata_document">1548</infon>
    <infon key="doi">10.15252/emmm.201404914</infon>
    <infon key="pmc_id">4568946</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>Immunoblotting for components of the MAPK pathway confirmed reactivation of p-ERK in the PDX derived from the vemurafenib-resistant metastases, although the p-ERK signal is heterogeneous in the pre-treatment PDX.</text>
      <annotation id="1">
        <infon key="type">Uniprot:P27361|Uniprot:P28482</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">160</infon>
        <location offset="78" length="3"/>
        <text>ERK</text>
      </annotation>
      <annotation id="2">
        <infon key="type">CHEBI:63637</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">161</infon>
        <location offset="110" length="11"/>
        <text>vemurafenib</text>
      </annotation>
      <annotation id="3">
        <infon key="type">Uniprot:P27361|Uniprot:P28482</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">162</infon>
        <location offset="159" length="3"/>
        <text>ERK</text>
      </annotation>
      <annotation id="4">
        <infon key="type">tissue:metastases</infon>
        <infon key="sourcedata_figure_annot_id">6</infon>
        <infon key="sourcedata_article_annot_id">193</infon>
        <location offset="132" length="10"/>
        <text>metastases</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4568946 Figure_7-C</id>
    <infon key="sourcedata_document">1548</infon>
    <infon key="doi">10.15252/emmm.201404914</infon>
    <infon key="pmc_id">4568946</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>Validation of the BRAF amplification was performed by qPCR on gDNA derived from the PDX, using primers for BRAF and CRAF and normalized on LINE expression. Bars represent the mean of three replicates, error bars indicate standard deviation. The results confirmed that BRAF was amplified in PDX derived from M032R2 and M032R5, but not from M032R1.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:673</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">168</infon>
        <location offset="18" length="4"/>
        <text>BRAF</text>
      </annotation>
      <annotation id="2">
        <infon key="type">NCBI gene:673</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">171</infon>
        <location offset="107" length="4"/>
        <text>BRAF</text>
      </annotation>
      <annotation id="3">
        <infon key="type">NCBI gene:5894</infon>
        <infon key="sourcedata_figure_annot_id">3</infon>
        <infon key="sourcedata_article_annot_id">172</infon>
        <location offset="116" length="4"/>
        <text>CRAF</text>
      </annotation>
      <annotation id="4">
        <infon key="type">NCBI gene:673</infon>
        <infon key="sourcedata_figure_annot_id">4</infon>
        <infon key="sourcedata_article_annot_id">173</infon>
        <location offset="268" length="4"/>
        <text>BRAF</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4568946 Figure_7-D</id>
    <infon key="sourcedata_document">1548</infon>
    <infon key="doi">10.15252/emmm.201404914</infon>
    <infon key="pmc_id">4568946</infon>
    <infon key="figure">Figure 7-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-D</infon>
    <passage>
      <offset>0</offset>
      <text>Presence of the MEK1T55delinsRT was analyzed by PCR using insertion-specific primers. As a control, primers amplifying exon 2 of MEK1WT were used. The insertion was found in M032R1.X1 and M032R4.X1.</text>
      <annotation id="1">
        <infon key="type">NCBI gene:5604</infon>
        <infon key="sourcedata_figure_annot_id">1</infon>
        <infon key="sourcedata_article_annot_id">175</infon>
        <location offset="16" length="4"/>
        <text>MEK1</text>
      </annotation>
      <annotation id="2">
        <infon key="type">NCBI gene:5604</infon>
        <infon key="sourcedata_figure_annot_id">2</infon>
        <infon key="sourcedata_article_annot_id">177</infon>
        <location offset="129" length="4"/>
        <text>MEK1</text>
      </annotation>
    </passage>
  </document>
</collection>
